🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Prenatal #triptan use appears safe for fetal #neurodevelopment, with no link to #ADHD, #autism, or intellectual disability. Results from a Norwegian #migraine study published in Neurology Journal. ow.ly/L0ff50W0r8b Helsedirektoratet 🇸🇯 Directorate of Health American Headache Society American Academy of Neurology National Headache Foundation (NHF)

Can weight loss improve #headache symptoms? Read a new review of the role of GLP-1 RAs, lifestyle changes, & surgeries in the care of headache and IIH by Drs McVige & Bowe (Ryan Bowe, MD), Lanie Masset & Abby Graff. ow.ly/kZYS50W0nhF American Headache Society @nhf @DENTintstitute @aanmember

An investigational oral therapy for #OSA, reduced apnea-hypopnea index by 55.6% over 26 weeks in the phase 3 SynAIRgy trial. Well tolerated, no serious adverse events reported. ow.ly/RqPK50W0rfa @ApnimedRx American Academy of Sleep Medicine National Sleep Foundation

Current evidence supports nerve blocks & trigger point injections for #headache Tx. Drs Khoury, Saikali, Hauser Chatterjee, Dominguez Moreno, Conger-Love, & Harshini Sirvisetty discuss non-#botox injections in an article: ow.ly/H9K450W0nE1 Dent Neurologic @UCLAhealth American Headache Society

🧠 A recent study highlights copathologies and non-#AD biomarkers in individuals with #Alzheimer Disease. Understanding these hidden complexities could play a role in diagnosis & management strategies! 🔗 Read more: ow.ly/jLUQ50W3qbu JAMA Neurology ISTAART Alzheimer's Association

⚠️ New Findings on #MS Treatment ⚠️ Patients taking generic fingolimod report higher relapse and adverse event rates compared to Gilenya. ow.ly/r7h550W4jwM #MultipleSclerosis Novartis #Gilenya @MSSociety #CMSC2025

A wearable bladder monitoring device is showing promise in predicting #UTIs for women with #MS. 🔗 Read more: ow.ly/gkTn50W3p4H #CMSC2025 #MultipleSclerosis @DfreeUS #MS #Incontinence National MS Society Amer. Urol. Assn.

From PSG to PPG: The evolution of #sleep #apnea diagnostics continues with home OSA tests & wearables. A review of modern sleep apnea Dx approaches by Drs Lee-Iannotti (Joyce Lee-Iannotti) & Chiang appears in our new issue: ow.ly/Hp9950W0ojY American Academy of Sleep Medicine BarrowNeurological Sleep Research Society

Dr. Laszlo Mechtler and his team discuss how IV infusion therapy at outpatient centers can provide quick #headache relief, reduce hospitalization, & improve treatment adherence. Read their article today: ow.ly/VBt650W0oHs @Dentinstitute American Headache Society @nhf American Migraine Foundation

Alice Cai, MD, a Sleep Fellow and Medical Director at Takeda, discusses the significant impact of living with narcolepsy type 1 and the potential of orexin science in this rare, neurological condition: ow.ly/zPBg50W1AUo #Takeda #sponsored

🚗 A new study reveals that over 50% of patients with multiple sclerosis discontinue infusion-based treatments due to travel-related challenges. ow.ly/AsMb50W6WMk #MultipleSclerosis #CMSC2025 @MSSociety Novartis

What's next in #intracerebral #hemorrhage surgery? Dr. Polster reviews lessons from the STICH, MISTIE III, & ENRICH studies & outlines how future trials must focus on timing, volume, & anatomy. ow.ly/XsCr50W0qiY American Heart Association American Academy of Neurology UChicago Medicine Stroke Association

Multi-modal screening for narcolepsy type 1 using polygenic risk and HLA typing shows high sensitivity and specificity. ow.ly/ptf250W6YFr #Narcolepsy #SleepHealth #Sleep2025 @aasmfoundation@TakedaPharma

🧠💤 Promising news for idiopathic hypersomnia: A new study shows Wakix may be an effective treatment option for this often-overlooked sleep disorder. ow.ly/tkBN50W6Yvu #IdiopathicHypersomnia #SleepHealth #Sleep2025 AASM Foundation Harmony Biosciences

Adolescents with #headache face challenges moving from pediatric to adult care. Drs Bazarsky, Washington, Scott, Strauss (Lauren Doyle Strauss, DO, FAHS), Slater, and O’Brien provide guidance for both pediatric and adult specialists: ow.ly/UzRX50W0qMs Hope O'Brien American Headache Society @nhf

😴 Sunosi significantly reduced excessive daytime sleepiness and improved obstructive sleep apnea symptoms and comorbidities according to a new study. ow.ly/S9yc50W6XX2 Axsome Therapeutics #SleepHealth #ObstructiveSleepApnea #DaytimeSleepiness #Sunosi #Sleep2025 AASM Foundation

For the first time, clinicians have a developed guidelines for de-escalating and discontinuing #MS therapies in patients where treatment reduction may be appropriate. 🔗 Read more: ow.ly/H49g50W6Xo2 ECTRIMS #MultipleSclerosis @MSSociety

#Ubrelvy treatment before #headache onset resolved prodromal #migraine symptoms such as photophobia, phonophobia, fatigue, & more. Results published in Nature Medicine. ow.ly/HqV050Wai1B @AbbVie American Headache Society American Migraine Foundation National Headache Foundation (NHF) @aanmember

Wendy Terry painted the cover image for this month's issue, titled "Heavy Head." Wendy's art expresses the emotional and physical aspects of experiencing #headaches. ow.ly/eMUg50W0TeS American Headache Society American Migraine Foundation @nhf American Academy of Neurology

Emerging Anticoagulation Therapies: A Key “Factor” in Secondary Stroke Prevention Following an Ischemic Stroke? S. Claiborne Johnston, MD, PhD, Co-Founder and Chief Medical Officer of Harbor Health ow.ly/fv2g50W7vam #Sponsored